From biomarkers to therapeutic targets: the promise of PD-L1 in thyroid autoimmunity and cancer

The programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) immune checkpoint proteins hold promise as diagnostic, prognostic, and therapeutic targets for precision oncology. By restoring antitumor T cell surveillance, the high degree of effectiveness of the immune checkpoint inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Andréa, Grégoire, Lassalle, Sandra, Guevara, Nicolas, Mograbi, Baharia, Hofman, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738901/
https://www.ncbi.nlm.nih.gov/pubmed/33391536
http://dx.doi.org/10.7150/thno.50333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738901/
https://www.ncbi.nlm.nih.gov/pubmed/33391536
http://dx.doi.org/10.7150/thno.50333

Ejemplares similares